Device Medical Device

(5154) Azurion 7 M20 Gc

Payments companies reported to CMS as associated with (5154) Azurion 7 M20 Gc. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$3,903associated payments (2023-2025)

68clinicians with associated payments

2companies reporting

By year

2023 $2,477

2024 $1,426

Payments reported as associated with (5154) Azurion 7 M20 Gc, per program year, as reported to CMS.

Who makes it

Philips Electronics North America Corporation $2,103 associated with (5154) Azurion 7 M20 Gc (2023-2025)
Philips North America LLC $1,801 associated with (5154) Azurion 7 M20 Gc (2023-2025)

Specialties most often involved

Interventional Cardiology $1,021

Diagnostic Radiology $910

Vascular & Interventional Radiology $640

Cardiovascular Disease $494

Clinical Cardiac Electrophysiology $179

Vascular Surgery $160

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with (5154) Azurion 7 M20 Gc

These are the largest totals companies reported as associated with (5154) Azurion 7 M20 Gc. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Roberto Scaffidi	Dover, DE	Interventional Cardiology	$217.14
Jeffrey Carstens	Omaha, NE	Cardiovascular Disease	$189.53
Jean Bismuth	Houston, TX	Vascular Surgery	$160.15
Barry Katzen	Miami, FL	Diagnostic Radiology	$144.19
Sammy Khatib	New Orleans, LA	Clinical Cardiac Electrophysiology	$136.90
Jonas Redmond	San Diego, CA	Vascular & Interventional Radiology	$132.46
Paul Teirstein	La Jolla, CA	Interventional Cardiology	$125.05
Matthew Price	La Jolla, CA	Interventional Cardiology	$125.05
Curtiss Stinis	La Jolla, CA	Interventional Cardiology	$125.05
Clinton Nichols	San Diego, CA	Diagnostic Radiology	$122.83

Prescribed (5154) Azurion 7 M20 Gc?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.